Recognizing and Minimizing Clinical Inertia in Type 2 Diabetes: A Case for Timely Treatment Intensification

On-Demand

This on-demand webinar reviews the current guideline recommendations for the treatment of type 2 diabetes, outlines the benefits and risks of various classes of antihyperglycemic agents including SGLT-2 exhibitors, and discusses clinical considerations for early combination therapy. Participants will learn how to describe the clinical and economic impact of clinical inertia, and be able to implement strategies to reduce clinical inertia in the management of patients with type 2 diabetes